Last Updated : October 13, 2005
Details
FilesGeneric Name:
Insulin aspart/insulin aspart protamine
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus
Manufacturer:
Novo Nordisk Canada Inc.
Brand Name:
NovoMix 30
Project Line:
Reimbursement Review
Project Number:
SR0041-000
Submission Type:
Initial
Indications:
Diabetes mellitus
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
(tentative)
Reconsideration requested.
Reconsideration on April 19, 2006
Files
Last Updated : October 13, 2005